Le Lézard
Classified in: Health
Subjects: NPT, RCL

Consumer Foodborne Illness Advocacy Group Reacts to USDA Announcement


STOP Foodborne Illness Applauds USDA for Tackling Salmonella in Poultry, Creating a Safer Food Supply

CHICAGO, Aug. 3, 2022 /PRNewswire/ -- The U.S. Department of Agriculture's (USDA) Food Safety and Inspection Service (FSIS) announced groundbreaking plans to declare Salmonella an adulterant.

In addition, the USDA has plans to establish enforceable raw poultry product standards. These include a uniform final product standard for all poultry products, requiring Salmonella testing for poultry flocks entering facilities, and discussing a zero-tolerance policy in an effort to prevent contaminated products from reaching consumers.

Salmonella remains a leading cause of foodborne illness in the US with an estimated 1.35 million cases of salmonellosis annually resulting in 420 deaths.

Stop Foodborne Illness (STOP; www.stopfoodborneillness.org) ? a national non-profit representing consumers impacted by food safety failures and collaborates with academia, the food industry, and government to prevent foodborne illnesses ? applauds the USDA-FSIS commitment to tackle the significant burden of illness caused by Salmonella in poultry.

"STOP supports meaningful and enforceable Salmonella product standards that determine which products can safely enter the market and those which cannot. We, along with consumers, have been petitioning the agency for these modern advancements, along with our colleagues from the Coalition for New Poultry Safety Program," says Mitzi Baum, CEO of STOP.

Chicken and turkey are major contributors to Salmonella sicknesses ? according to the US Centers for Disease Control and Prevention. "Until today's announcement, Salmonella standards haven't been meaningfully updated for over 25 years, even though science has advanced dramatically," adds Baum.

STOP recognizes the amount of work that needs to be done to get the new standards right. "Deputy Under Secretary Eskin's plan to set enforceable standards limiting Salmonella in poultry is a historic step toward a safer food supply," said former FSIS administrator and STOP board member, Michael Taylor. "This is an initiative that I hope consumers and industry support." 

About Stop Foodborne Illness (STOP): STOP is a 28-year-old non-profit that collaborates with partners in academia, the food industry, and government to prevent foodborne illnesses. We advocate for effective food safety policies and facilitate culture change to increase food safety.

Media Contact:
Ruth Wyatt
219-771-9842
[email protected]

SOURCE Stop Foodborne Illness


These press releases may also interest you

at 02:48
Today, RaySearch Laboratories AB (publ)  publishes its Annual Report for the financial year 2023. The report is held available on RaySearch's website, under the section Investors.  This information is information that RaySearch Larboratiories AB...

at 02:43
Shareholders of Zinzino AB (publ) are hereby invited to the annual general meeting on Monday, May 27, 2024, at 1:30 PM at the company's premises at Hulda Mellgrens gata 5 in Gothenburg. Registration begins at 1:15 PM. The company aims to webcast the...

at 02:41
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2023. The annual report is now available on the company's website. "Implantica had a very...

at 02:08
Revenue amounted to ?498.8m (?419.3m), an increase of 18.9% with an organic growth of 14.2%.Operating profit (EBIT) was ?19.0m (?10.7m), an increase of 78.0%, representing an operating margin of 3.8% (2.6%).Net profit amounted to ?6.5m (?2.1m), which...

at 02:00
Amwins Global Risks is delighted to announce Classic Cars and Cotswolds, an auction to raise money for the Matthew Wilson Multiple Myeloma Fund at Blood Cancer UK. The online auction opens today and features Ferraris, Aston Martins, a Rolls Royce, a...

at 01:35
Regulatory News: Sensorion (FR0012596468 ? ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces...



News published on and distributed by: